Robert Swann is a Principal in Global Market Access at ICON plc, where they leverage extensive expertise in insights, evidence, and value within the healthcare sector. They served as the Director of HTA and Market Access at HEOR from 2021 to 2023 and held various leadership roles in market access, pricing, and reimbursement throughout their career, including Senior Director positions at PAREXEL and HERON. Robert's educational background includes an MBA from the University of Warwick and a Post Graduate Diploma in Clinical Science from Cardiff University. Their experience spans several decades in the medical device and pharmaceutical industries, highlighting a strong foundation in both technical and commercial operations.
This person is not in the org chart
This person is not in any teams
This person is not in any offices